AstraZeneca (AZN) Withdraws App for Ovarian-Cancer Treatment in Europe

September 21, 2016 7:43 AM EDT Send to a Friend
AstraZeneca (NYSE: AZN) is said to have withdrawn its application for approval of cediranib ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login